Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 33 Records) |
| Query Trace: Neoplasms and ELAC2[original query] |
|---|
| Role of HPC2/ELAC2 in hereditary prostate cancer. Cancer research 2001 Sep 61 (17): 6494-9. Wang L, McDonnell S K, Elkins D A, Slager S L, Christensen E, Marks A F, Cunningham J M, Peterson B J, Jacobsen S J, Cerhan J R, Blute M L, Schaid D J, Thibodeau S |
| Loss of heterozygosity of the putative prostate cancer susceptibility gene HPC2/ELAC2 is uncommon in sporadic and familial prostate cancer. Cancer research 2001 12 61 (24): 8651-3. Wu Y Q, Chen H, Rubin M A, Wojno K J, Cooney K |
| ELAC2 and prostate cancer risk in Afro-Caribbeans of Tobago. Human genetics 2002 Oct 111 (4-5): 398-400. Shea Patrick R, Ferrell Robert E, Patrick Alan L, Kuller Lewis H, Bunker Clareann |
| HPC2/ELAC2 polymorphisms and prostate cancer risk: analysis by age of onset of disease. British journal of cancer 2002 Oct 87 (8): 905-8. Meitz J C, Edwards S M, Easton D F, Murkin A, Ardern-Jones A, Jackson R A, Williams S, Dearnaley D P, Stratton M R, Houlston R S, Eeles R A, |
| Association of HPC2/ELAC2 polymorphisms with risk of prostate cancer in a population-based study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003 Sep 12 (9): 876-81. Stanford Janet L, Sabacan Leah P, Noonan Elizabeth A, Iwasaki Lori, Shu Jianfen, Feng Ziding, Ostrander Elaine |
| Ser217Leu polymorphism of the HPC2/ELAC2 gene associated with prostatic cancer risk in Japanese men. International journal of cancer. Journal international du cancer 2003 Nov 107 (2): 224-8. Takahashi Hiroyuki, Lu Wei, Watanabe Masatoshi, Katoh Takahiko, Furusato Masakuni, Tsukino Hiromasa, Nakao Hiroyuki, Sudo Akemi, Suzuki Hiroyoshi, Akakura Koichiro, Ikemoto Isao, Asano Kouji, Ito Takaaki, Wakui Shin, Muto Tomoko, Hano Hiros |
| ELAC2/HPC2 polymorphisms, prostate-specific antigen levels, and prostate cancer. Journal of the National Cancer Institute 2003 Jun 95 (11): 818-24. Severi Gianluca, Giles Graham G, Southey Melissa C, Tesoriero Andrea, Tilley Wayne, Neufing Petra, Morris Howard, English Dallas R, McCredie Margaret R E, Boyle Peter, Hopper John |
| Mutational analysis of susceptibility genes RNASEL/HPC1, ELAC2/HPC2, and MSR1 in sporadic prostate cancer. Genes, chromosomes & cancer 2003 12 39 (2): 119-25. Nupponen Nina N, Wallén Mika J, Ponciano Damaris, Robbins Christiane M, Tammela Teuvo L J, Vessella Robert L, Carpten John D, Visakorpi Tap |
| HPC2/ELAC2 gene variants associated with incident prostate cancer. Journal of human genetics 2003 48 (12): 634-8. Adler David, Kanji Nimira, Trpkov Kiril, Fick Gordon, Hughes Rhiannon |
| Meta-analysis of associations of the Ser217Leu and Ala541Thr variants in ELAC2 (HPC2) and prostate cancer. American journal of human genetics 2002 Dec 71 (6): 1475-8. Camp Nicola J, Tavtigian Sean |
| Association of HPC2/ELAC2 polymorphism with prostate cancer risk in a Japanese population. Anticancer research 0 22 (6B): 3507-11. Suzuki Kazuhiro, Ohtake Nobuaki, Nakata Seiji, Takei Tomoyuki, Matsui Hiroshi, Ono Yoshihiro, Nakazato Haruki, Hasumi Masaru, Koike Hidekazu, Ito Kazuto, Fukabori Yoshitatsu, Kurokawa Kohei, Yamanaka Hidetos |
| Association of common missense changes in ELAC2 ( HPC2) with prostate cancer in a Japanese case-control series. Journal of human genetics 2002 47 (12): 641-8. Fujiwara Hiromichi, Emi Mitsura, Nagai Hisaki, Nishimura Taiji, Konishi Noboru, Kubota Yoshinobu, Ichikawa Tomohiko, Takahashi Satoru, Shuin Taro, Habuchi Tomonori, Ogawa Osamu, Inoue Katsuki, Skolnick Mark H, Swensen Jeff, Camp Nicola J, Tavtigian Sean |
| HPC2/ELAC2 polymorphism associated with Japanese sporadic prostate cancer. The Prostate 2004 Nov 61 (3): 248-52. Yokomizo Akira, Koga Hirofumi, Kinukawa Naoko, Tsukamoto Taiji, Hirao Yoshihiko, Akaza Hideyuki, Mori Mitsuru, Naito Sei |
| Characterization of linkage disequilibrium structure, mutation history, and tagging SNPs, and their use in association analyses: ELAC2 and familial early-onset prostate cancer. Genetic epidemiology 2005 Apr 28 (3): 232-43. Camp Nicola J, Swensen Jeff, Horne Benjamin D, Farnham James M, Thomas Alun, Cannon-Albright Lisa A, Tavtigian Sean |
| Analysis of polymorphic patterns in candidate genes in Israeli patients with prostate cancer. The Israel Medical Association journal : IMAJ 2003 Oct 5 (10): 741-5. Figer Arie, Friedman Tal, Manguoglu Ayse Esra, Flex Dov, Vazina Amnon, Novikov Ilia, Shtrieker Avi, Sidi A Ami, Tichler Thomas, Sapir Einat Even, Baniel Jack, Friedman Eit |
| Association of hereditary prostate cancer gene polymorphic variants with sporadic aggressive prostate carcinoma. The Prostate 2006 Jan 66 (1): 49-56. Noonan-Wheeler Ferrin C, Wu William, Roehl Kimberly A, Klim Aleksandra, Haugen John, Suarez Brian K, Kibel Adam |
| Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005 Apr 14 (4): 949-57. Rennert Hanna, Zeigler-Johnson Charnita M, Addya Kathakali, Finley Matthew J, Walker Amy H, Spangler Elaine, Leonard Debra G B, Wein Alan, Malkowicz S Bruce, Rebbeck Timothy |
| Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene. British journal of cancer 2005 Mar 92 (6): 1159-64. Maier C, Haeusler J, Herkommer K, Vesovic Z, Hoegel J, Vogel W, Paiss |
| Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases. The Prostate 2008 Dec 68 (16): 1790-7. Robbins Christiane M, Hernandez Wenndy, Ahaghotu Chiledum, Bennett James, Hoke Gerald, Mason Terry, Pettaway Curtis A, Vijayakumar Srinivasan, Weinrich Sally, Furbert-Harris Paulette, Dunston Georgia, Powell Isaac J, Carpten John D, Kittles Rick |
| Sequence variants of elaC homolog 2 (Escherichia coli) (ELAC2) gene and susceptibility to prostate cancer in the Health Professionals Follow-Up Study. Carcinogenesis 2008 May 29 (5): 999-1004. Chen Yen-Ching, Giovannucci Edward, Kraft Peter, J Hunter Dav |
| ELAC2 polymorphisms and prostate cancer risk: a meta-analysis based on 18 case-control studies. Prostate cancer and prostatic diseases 2010 Sep 13 (3): 270-7. Xu B, Tong N, Li J-m, Zhang Z-d, Wu H |
| Single and multivariate associations of MSR1, ELAC2, and RNASEL with prostate cancer in an ethnic diverse cohort of men. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010 Feb 19 (2): 588-99. Beuten Joke, Gelfond Jonathan A L, Franke Jennifer L, Shook Stacey, Johnson-Pais Teresa L, Thompson Ian M, Leach Robin |
| Prognostic role of genetic biomarkers in clinical progression of prostate cancer. Experimental & molecular medicine 2015 47 e176. Alvarez-Cubero Maria Jesus, Martinez-Gonzalez Luis Javier, Saiz Maria, Carmona-Saez Pedro, Alvarez Juan Carlos, Pascual-Geler Manrique, Lorente Jose Antonio, Cozar Jose Manu |
| Association between RNASEL, MSR1, and ELAC2 single nucleotide polymorphisms and gene expression in prostate cancer risk. Urologic oncology 2016 Jun . Alvarez-Cubero Maria Jesus, Pascual-Geler Manrique, Martinez-Gonzalez Luis Javier, Expósito Ruiz Manuela, Saiz Maria, Cozar Jose Manuel, Lorente Jose Anton |
| Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomy. Oncotarget 2019 Aug 10 (48): 4973-4986. Schroeder Cornelia, Navid-Hill Elham, Meiners Jan, Hube-Magg Claudia, Kluth Martina, Makrypidi-Fraune Georgia, Simon Ronald, Büscheck Franziska, Luebke Andreas M, Goebel Cosima, Lang Dagmar S, Weidemann Sören, Neubauer Emily, Hinsch Andrea, Jacobsen Frank, Lebok Patrick, Michl Uwe, Pehrke Dirk, Huland Hartwig, Graefen Markus, Schlomm Thorsten, Sauter Guido, Höflmayer Dor |
| Prevalence of the Ser217Leu Variant of the ELAC2 Gene and Its Association with Prostate Cancer in Population of the Littoral Region of Cameroon. Prostate cancer 2019 7 2019 5974928. Djomkam Alexandra Lindsey Zune, Beyeme Sala Theodore, Baari Memba Clarisse, Njimoh Dieudonné Lem |
| A Study of Ser217Leu and Ala541Thr Polymorphism in the Men Afflicted with Prostate Cancer and in the Men being Suspicious of Prostate Cancer. Asian Pacific journal of cancer prevention : APJCP 2020 6 21 (6): 1551-1557. Zahiri Zahra, Zahiri Fatem |
| Genetic Analysis of a Family with Multiple Incidences of Prostate Cancer. Case reports in oncology 2022 3 15 (1): 86-90. Feng Ninghan, Liu Fengping, Xu Xinyu, Wang Yang, Sheng Qingsong, Zhu Kuich |
| Evaluation of HNF1B, KLK3, ELAC2, TMPRSS2-ERG, and CTNNB1 polymorphisms associated with prostate cancer in samples of patients from HUPE-UERJ. The Prostate 2023 10 . Raphaela Dos Santos Menezes, Maria Cristina Dornas, Carlos Frederico Ferreira Campos, Daniela Bouzas Rodeiro, Fabricio Borges Carrerette, Romulo Vianna Oliveira, Brenda Amaral de Souza, Gabriele Alves de Souza Carvalho, Ingrid Alexandre de Abreu Brito, Dayse Aparecida Silva, Ronaldo Damião, Luís Cristóvão Por |
| Carriage of Ser217Leu and Ala541Thr Variants of ELAC2 Gene and Risk Factors in Patients with Prostate Cancer in Burkina Faso. Prostate cancer 2023 1 2022 3610089. Traoré Aïda Djé Djénèba, Ky Bienvenu Désiré, Traoré Lassina, Zohoncon Théodora M, Zouré Abdou Azaque, Yonli Albert Théophane, Sombié Herman Karim, Sorgho Pegdwendé Abel, Elvira Bazié Bapio Valery Jean Télesphore, Tovo Sessi Frida Appoline, Kadanga Essonan, Bakyono Bélélé Siméon, Traore Kalifou, Ouédraogo Teega-Wendé Clarisse, Djigma Florencia W, Simpore Jacqu |
- Page last reviewed:Feb 1, 2024
- Content source: